Skip to content
2000
Volume 15, Issue 14
  • ISSN: 1568-0266
  • E-ISSN: 1873-4294

Abstract

XR5944 is a potent anticancer drug with a novel DNA binding mode: DNA bisintercalationg with major groove binding. XR5944 can bind the estrogen response element (ERE) sequence to block ER-ERE binding and inhibit ERα activities, which may be useful for overcoming drug resistance to currently available antiestrogen treatments. This review discusses the progress relating to the structure and function studies of specific DNA recognition of XR5944. The sites of intercalation within a native promoter sequence appear to be different from the ideal binding site and are context- and sequence- dependent. The structural information may provide insights for rational design of improved EREspecific XR5944 derivatives, as well as of DNA bis-intercalators in general.

Loading

Article metrics loading...

/content/journals/ctmc/10.2174/1568026615666150413155608
2015-07-01
2025-05-29
Loading full text...

Full text loading...

/content/journals/ctmc/10.2174/1568026615666150413155608
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test